An Ireland-based angel group has been operating for 5 years and has invested a total of €15-20 million in 15-20 companies, of which have raised more than €40 million thus far. The group focuses on the life science industry where they have made their largest investments, while also having several deals in other sectors such as energy and social media. The group seeks to make 3-4 investments a year, with an annual investment size of €3-5 million. The group typically invests €500,000-€1 million per company. The group has done syndicates with Scotland in the past, and is potentially open to syndicating with Angels in other locations. The group typically makes investments in Ireland-based companies, though is looking to make new investments in other regions in Europe, USA, and Australia.
The group has a particular focus in medical devices, and is also open to diagnostics, drug delivery, and drug repackaging. The group will not invest in therapeutics, pharmaceuticals, or new small molecules, and is agnostic in terms of phase of development.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com
Next Phase Newsletter 
Leave a comment